+966 568813716 [email protected]

Post Graduate

Home / E-Lessons / Medical Students / Archive by category "Post Graduate" (Page 2)
13
Feb
2026
BLS – detailed for exam
Posted On February 13, 2026  By [email protected]  And has No Comment

Read More

05
Feb
2026
Can Mirtazapine treat ADHD? What is the Connection?
Posted On February 5, 2026  By [email protected]  And has No Comment

From sleepless nights to scattered thoughts, the quest for ADHD relief takes an unexpected turn down the path of an antidepressant that might just be the game-changer patients have been waiting for. As individuals with Attention Deficit Hyperactivity Disorder (ADHD) continue to search for effective treatments, […]

Read More

27
Jul
2025
Gabapentin and Dementia Risk
Posted On July 27, 2025  By [email protected]  And has No Comment

Based on the Medscape article about gabapentin and dementia risk, sum up. Gabapentin and Dementia Risk: New Research Findings Study Overview • Anticonvulsant gabapentin linked to increased cognitive decline risk • Led by Nafis Eghrari, Case Western Reserve University • Published in Regional Anesthesia & Pain […]

Read More

27
Jul
2025
Heavy cannabis use and long-term memory
Posted On July 27, 2025  By [email protected]  And has No Comment

Based on the article from Psychiatrist.com, here’s a summary of the key findings about heavy cannabis use and long-term memory: Study Overview and Motivation Researchers led by Joshua Gowin from the University of Colorado School of Medicine conducted the largest study to date examining cannabis effects […]

Read More


17
Jun
2025
Eye Signs in different Psychiatric Disorders
Posted On June 17, 2025  By [email protected]  And has No Comment

Eye signs and symptoms provide valuable diagnostic and monitoring information across various psychiatric disorders. Here’s an in-depth analysis of these ocular manifestations: Schizophrenia Smooth Pursuit Eye Movement (SPEM) Abnormalities: Deficits in smooth pursuit and an excess of ‘jerky’ eye movements were one of the earliest reported […]

Read More

23
May
2025
Sulpiride and AmiSulpiride is there a a clinical difference ?
Posted On May 23, 2025  By [email protected]  And has No Comment

Sulpiride and amisulpride are both benzamide antipsychotics primarily used in the treatment of schizophrenia and, in some cases, depression or anxiety disorders. Despite their similarities, they have important differences in structure, pharmacodynamics, and clinical applications. 🔬 Core Molecular Differences Property Sulpiride Amisulpride Chemical Class Substituted benzamide […]

Read More

18
May
2025
Dialectical Behavior Therapy (DBT) Techniques for Borderline Personality Disorder
Posted On May 18, 2025  By [email protected]  And has No Comment

DBT DBT, developed by Dr. Marsha Linehan, is considered the gold standard treatment for Borderline Personality Disorder (BPD). Here are the core techniques and components: Core Modules and Skills 1. Mindfulness Skills 2. Distress Tolerance 3. Emotion Regulation 4. Interpersonal Effectiveness Treatment Structure 1. Individual Therapy […]

Read More

18
May
2025
Comparison of Long-Acting Injectable (LAI) Antipsychotic Medications
Posted On May 18, 2025  By [email protected]  And has No Comment

First-Generation LAIs Haloperidol Decanoate (Haldol Decanoate) Fluphenazine Decanoate (Prolixin Decanoate) Second-Generation LAIs Risperidone Microspheres (Risperdal Consta) Paliperidone Palmitate (Multiple Formulations) Aripiprazole LAIs Olanzapine Pamoate (Zyprexa Relprevv) Comparative Factors Efficacy Rankings Metabolic Profile (Best to Worst) EPS Risk (Lowest to Highest) Prolactin Elevation (Lowest to Highest) Convenience […]

Read More

18
May
2025
Why did Olanzapine Long-Acting Antipsychotics fail to continue?
Posted On May 18, 2025  By [email protected]  And has No Comment

Olanzapine pamoate (Zyprexa Relprevv) actually does exist as a long-acting injectable (LAI) antipsychotic, but it has had a more limited clinical adoption compared to other LAIs for several important reasons: This combination of safety concerns, logistical requirements, and market competition limited the widespread adoption of olanzapine […]

Read More


Page 2 of 19